Efficient automated syntheses of high specific activity 6‐[18F]fluorodopamine using a diaryliodonium salt precursor
- 23 December 2015
- journal article
- research article
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 59 (1) , 30-34
Abstract
6‐[18F]Fluorodopamine (6‐[18F]F‐DA) is a positron emission tomography radiopharmaceutical used to image sympathetic cardiac innervation and neuroendocrine tumors. Imaging with 6‐[18F]F‐DA is constrained, in part, by the bioactivity and neurotoxicity of 6‐[19F]fluorodopamine. Furthermore, routine access to this radiotracer is limited by the inherent difficulty of incorporation of [18F]fluoride into electron‐rich aromatic substrates. We describe the simple and direct preparation of high specific activity (SA) 6‐[18F]F‐DA from no‐carrier‐added (n.c.a.) [18F]fluoride. Incorporation of n.c.a. [18F]fluoride into a diaryliodonium salt precursor was achieved in 50–75% radiochemical yields (decay corrected to end of bombardment). Synthesis of 6‐[18F]F‐DA on the IBA Synthera® and GE TRACERlab FX‐FN automated platforms gave 6‐[18F]F‐DA in >99% chemical and radiochemical purities after HPLC purification. The final non‐corrected yields of 6‐[18F]F‐DA were 25 ± 4% (n = 4, 65 min) and 31 ± 6% (n = 3, 75 min) using the Synthera and TRACERlab modules, respectively. Efficient access to high SA 6‐[18F]F‐DA from a diaryliodonium salt precursor and n.c.a. [18F]fluoride is provided by a relatively subtle change in reaction conditions – replacement of a polar aprotic solvent (acetonitrile) with a relatively nonpolar solvent (toluene) during the critical radiofluorination reaction. Implementation of this process on common radiochemistry platforms should make 6‐[18F]F‐DA readily available to the wider imaging community.Keywords
Funding Information
- National Institutes of Health (R01EB015536)
This publication has 42 references indexed in Scilit:
- A Fluoride-Derived Electrophilic Late-Stage Fluorination Reagent for PET ImagingScience, 2011
- First Experience with Clinical-Grade [18F]FPP(RGD)2: An Automated Multi-step Radiosynthesis for Clinical PET StudiesMolecular Imaging and Biology, 2011
- Fluoride-promoted ligand exchange in diaryliodonium saltsJournal of Fluorine Chemistry, 2010
- Improved Arene Fluorination Methodology for I(III) SaltsOrganic Letters, 2010
- Regiospecific Reductive Elimination from Diaryliodonium SaltsAngewandte Chemie International Edition, 2010
- Comparison of 6-18F-Fluorodopamine PET with 123I-Metaiodobenzylguanidine and 111In-Pentetreotide Scintigraphy in Localization of Nonmetastatic and Metastatic PheochromocytomaJournal of Nuclear Medicine, 2008
- The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel–Lindau syndromeEuropean Journal of Endocrinology, 2007
- Diagnostic Localization of PheochromocytomaAnnals of the New York Academy of Sciences, 2002
- Direct radiofluorination of dopamine: 18F-labeled 6-fluorodopamine for imaging cardiac sympathetic innervation in humans using positron emission tomographyNuclear Medicine and Biology, 1996
- Synthesis of 6‐[18F]fluorodopamine, 6‐[18F]fluoro‐m‐tyramine and 4‐[18F]fluoro‐m‐tyramine+Journal of Labelled Compounds and Radiopharmaceuticals, 1995